Skip to content
Trualt Bioenergy logo

Trualt Bioenergy

TRUALT NSE
₹369.45 +9.80 (+2.72%)
P/E
20.27
View as Markdown
MCP
Close 4 Nov 2026 ₹369.45 −44.80 −10.8% 1Y
Start ₹414.25

Key Fundamentals

MicrocapConsumer GoodsFMCG

Price-based figures as of · EPS basis: Consolidated · TTM

ROCE
10.40%
Debt to Equity
1.09
EPS (TTM)
₹18.23
Book Value
₹188.81
Market Cap
—
P/E (TTM)
20.27
P/B
1.96
ROE
8.38%
Dividend Yield
0.00%
EBITDA
₹376 Cr
52W High
₹542.00
52W Low
₹310.20
Day Range
₹362.65 – ₹375.00
Volume
1,11,342

Peer Comparison

Fast Moving Consumer Goods › FMCG › Agricultural Products › Other Agricultural Products

Trualt Bioenergy peer comparison
LT Foods
₹410.1022.24₹14,281 Cr2.910.73%14.70%17.60%₹11,633 Cr₹640 Cr
KRBL
₹408.6512.33₹9,318 Cr1.501.12%11.70%15.20%₹6,009 Cr₹758 Cr
Gujarat Ambuja Exports
₹152.0916.77₹6,847 Cr1.940.20%9.72%12.50%₹6,032 Cr₹416 Cr
Kaveri Seed Company
₹680.2514.02₹3,469 Cr1.730.75%15.00%15.80%₹1,279 Cr₹249 Cr
Trualt Bioenergy (this company)
₹369.4520.27₹3,167 Cr1.960.00%8.38%10.40%₹2,050 Cr₹159 Cr
Amir Chand Jagdish Kumar (Exports)
₹222.5715.79₹2,241 Cr2.330.00%15.80%15.70%₹2,627 Cr₹132 Cr
GRM Overseas
₹92.9823.84₹1,926 Cr3.210.48%14.20%14.00%₹1,869 Cr₹77 Cr
Median 7 companies₹369.4516.77₹3,469 Cr1.960.48%14.20%15.20%₹2,627 Cr₹249 Cr

Comparable companies in the same industry. Market cap, P/E and P/B use the latest price; other metrics are as reported in filings. A dash means the figure is not published for that company.

Tapetide Score

Data-driven rating, 0–100, as of . How it works →

Overall score

37 Weak

Data confidence 98/100

pledge:39%

Category scores

Quality
31
Poor
Returns, margins, earnings quality 22% weight
Valuation
39
Weak
Cheap vs sector & own history 24% weight
Growth
34
Poor
Sales & profit trajectory 9% weight
Financial Health
24
Poor
Solvency, leverage, coverage 9% weight
Momentum
17
Poor
Trend strength, vol-adjusted 12% weight
Ownership
77
Strong
FII/DII/promoter flows 24% weight

The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.

Key Insights

Strengths

1
  • Company is expected to give good quarter

Weaknesses

4
  • Stock is trading at 2.50 times its book value
  • Though the company is reporting repeated profits, it is not paying out dividend
  • Promoters have pledged 36.8% of their holding.
  • Working capital days have increased from -31.2 days to 63.4 days

Technical Indicators

Technical signals: verdict and indicator counts
GroupSignalBearishNeutralBullish
OverallStrong Bearish1252
OscillatorsNeutral252
Moving AveragesStrong Bearish1000

Key readings

RSI (14)
33.46
Neutral
MACD (12,26,9)
−19.47
Bearish
SMA (50)
422.88
Bearish
SMA (200)
433.73
Bearish

As of

Growth Rate

From the financial statements below. 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025; TTM: four quarters to Jun 2026 against Jun 2025.

Revenue

Revenue growth by window
3Y+31.38%
1Y−9.43%
TTM+1.84%

Net profit

Net profit growth by window
3Y+40.46%
1Y−34.01%
TTM−8.09%

Operating cash flow

Operating cash flow growth by window
3YTurned negative
1YTurned negative
TTM—

TTM: Reported once a year, so there is no trailing-twelve-month figure.

Operating margin· change in pp

Operating margin growth by window
3Y+3.00 pp
1Y+0.59 pp
TTM+2.28 pp

Revenue by year

Revenue by year, ₹ crore
Mar 2023₹762 Cr
Mar 2024₹1,223 Cr
Mar 2025₹1,908 Cr
Mar 2026₹1,728 Cr

Net profit by year

Net profit by year, ₹ crore
Mar 2023₹35.00 Cr
Mar 2024₹32.00 Cr
Mar 2025₹147 Cr
Mar 2026₹97.00 Cr

AI Analysis — Bull vs Bear

Generated 6 Jul 2026
AI opinion · based on fundamentals
Risk high

TruAlt Bioenergy Ltd is a small-cap FMCG company with a market cap of ~Rs 3,975 Cr trading at a PE of 41.4x. While the company delivered strong 3-year compounded sales growth of 31% and profit growth of 39%, the trailing twelve months show a revenue decline of 9% and profit decline of 35%, signaling a sharp recent slowdown.

Bull Case 6
  • Strong 3-year compounded sales CAGR of 31%, indicating robust medium-term revenue expansion
  • 3-year compounded profit CAGR of 39%, demonstrating ability to grow earnings faster than revenue over the medium term
  • 3-year average ROE of 14%, reflecting decent capital efficiency over the medium term
  • Price-to-book ratio of 2.64x is not excessively stretched for an FMCG company with demonstrated growth history
  • Company has been reporting repeated profits, indicating a fundamentally viable business model
  • Market cap of Rs 3,975 Cr places it in the small-to-mid cap space with potential runway for growth if execution recovers
Bear Case 8
  • TTM revenue declined 9%, a sharp reversal from the 31% three-year CAGR, suggesting demand or execution challenges
  • TTM profit declined 35%, indicating significant margin compression or operational deterioration in the most recent period
  • Promoters have pledged 36.8% of their holding, raising governance and forced-selling risk
  • Working capital days deteriorated sharply from -30.9 days to 64.3 days, indicating capital is getting locked up in operations
  • PE of 41.4x is elevated especially given the TTM profit decline of 35%, suggesting the stock is priced for growth that is not currently materializing
  • Zero dividend yield despite repeated profits indicates no direct shareholder returns
  • Low interest coverage ratio suggests debt servicing burden relative to operating earnings
  • Last year ROE dropped to 8% from 3-year average of 14%, showing deteriorating return on equity

This is AI-generated analysis, not financial advice. Do your own due diligence.

AI News Digest

121d ago

TL;DR: TruAlt Bioenergy faces a notable earnings decline with FY26 net profit down 34% and falling revenues, signaling operational pressure in its core FMCG/bioenergy business. On the positive side, the ₹150 Cr government grant for SAF diversifies its revenue base into aviation fuel. The large ₹2,500 Cr related party transactions with Nirani Sugars warrant governance monitoring. The trend is mixed — new capacity investments are forward-looking, but profitability deterioration needs to reverse for sentiment to improve.

Headwinds 2
  • FY26 net profit drops 34% Jun 23

    Consolidated net profit fell to ₹9,686.98 lakh in FY26 from ₹14,663.85 lakh in FY25, while revenue from operations also declined to ₹1,72,750.66 lakh.

  • Large ₹2,500 Cr RPTs sought Jun 08

    Trualt Bioenergy is seeking postal ballot approval for material related party transactions worth up to ₹2,500 Crores with Nirani Sugars Limited for FY 2026-27, raising governance scrutiny.

Positives 1
  • ₹150 Cr govt aid for SAF Jun 18

    Secured ₹150 crore under PM JI-VAN Yojana for a 10 crore litre Sustainable Aviation Fuel plant in Bagalkot, expanding into high-growth aviation fuel segment.

Neutral 2
  • Promoter shares unencumbered in FY26 Jun 22

    Promoter Vijaykumar Murugesh Nirani declared no new encumbrances on TruAlt Bioenergy shares in FY26, complying with SEBI takeover regulations.

  • Investor meet on June 12 Jun 08

    TruAlt Bioenergy hosted a virtual group meeting with analysts and institutional investors on June 12, 2026 as part of the InsightX 2026-Choice Virtual Conference.

Quarterly Results

₹ Cr
TRUALT quarterly results, ₹ crore
Particulars Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Sales
197
388
415
907
304
115
713
596
627
811
Expenses
184
371
291
753
262
119
579
466
494
710
Operating Profit
14
17
125
154
42
−5
134
129
133
101
OPM %
7%
4.5%
30%
17%
14%
−4%
19%
22%
21%
12%
Other Income
15
17
15
14
23
15
18
31
15
13
Interest
35
34
36
39
38
39
40
44
44
42
Depreciation
16
16
18
18
21
21
22
23
25
24
PBT
−22
−16
86
111
6
−49
90
94
78
47
Tax %
0%
15%
13%
−1%
18%
−23%
23%
27%
24%
26%
Net Profit
−22
−19
75
112
5
−38
69
69
59
35
EPS (₹)
−3.05
−2.64
10.65
15.81
0.67
−4.42
8.08
7.91
6.66
—

Sep 2026: from the results filed on 23 Oct 2026, ahead of the full statement, so some rows are blank.

Profit & Loss

₹ Cr
TRUALT profit and loss, annual, ₹ crore
Particulars Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
762
1,223
1,908
1,728
2,050
Expenses
657
1,035
1,599
1,438
1,659
Operating Profit
105
188
309
290
392
OPM %
14%
15%
16%
17%
19%
Other Income
0
57
61
86
78
Interest
35
143
144
160
166
Depreciation
21
57
67
86
90
PBT
49
45
159
130
213
Tax %
28%
29%
8%
25%
—
Net Profit
35
32
147
97
159
EPS (₹)
5.81
5.21
20.76
11.19
18.23
Div. Payout %
0%
0%
0%
0%
—

Balance Sheet

₹ Cr
TRUALT balance sheet, annual, ₹ crore
Particulars Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
61
61
71
86
Reserves
179
204
698
1,435
Borrowings
1,150
1,685
1,557
1,652
Other Liabilities
465
469
704
606
Total Liabilities
1,856
2,418
3,030
3,778
Fixed Assets
1,302
1,427
1,826
2,185
CWIP
10
201
3
68
Investments
0
10
4
4
Other Assets
545
780
1,197
1,521
Total Assets
1,856
2,418
3,030
3,778

Cash Flow

₹ Cr
TRUALT cash flow, annual, ₹ crore
Particulars Mar 2023Mar 2024Mar 2025Mar 2026
Operating
233
35
342
−296
Investing
−1,149
−384
−255
−413
Financing
920
367
40
648
Net Cash Flow
5
19
126
−62
Free Cash Flow
−42
−321
82
−806
CFO/OP
222
21
110
−99

Ratios

TRUALT financial ratios, annual
Particulars Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
41
89
65
86
Inventory Days
112
72
60
173
Days Payable
225
70
139
89
Cash Conversion Cycle
−72
92
−14
170
Working Capital Days
8
−130
−27
63
ROCE %
—
11%
14%
10%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Trualt Bioenergy insights

63 extracted metrics across FY22–FY27.

Shareholding Pattern

As of Sep 2026

  • Promoters 71.38%
  • Public 10.67%
  • DIIs 9.09%
  • Others 8.24%
  • FIIs 0.63%

39.20% of promoter holding pledged as of Sep 2026

Change vs previous quarter

Documents

Frequently Asked Questions about Trualt Bioenergy

What does TruAlt Bioenergy Ltd do?
Incorporated in 2021, Trualt Bioenergy Limited is engaged in the production of biofuels, with a primary focus on the ethanol sector.
Where is TruAlt Bioenergy Ltd (TRUALT) listed?
TruAlt Bioenergy Ltd trades as TRUALT on the NSE and under code 544545 on the BSE.
Which sector does TruAlt Bioenergy Ltd belong to?
TruAlt Bioenergy Ltd is classified under the FMCG sector, in the Agricultural Products industry.
What is the PE ratio of TruAlt Bioenergy Ltd?
TruAlt Bioenergy Ltd trades at a PE ratio of 20.27 as of 4 Nov 2026, on earnings per share of ₹18.23, against a book value of ₹188.81 per share.
What is the 52-week high and low of TruAlt Bioenergy Ltd?
Over the last 52 weeks TruAlt Bioenergy Ltd has traded between ₹310.2 and ₹542 as of 4 Nov 2026.
What is the Return on Equity (ROE) of TruAlt Bioenergy Ltd?
TruAlt Bioenergy Ltd reported a return on equity of 8.38%. Its debt-to-equity ratio is 1.09.

Company Information

Incorporated in 2021, Trualt Bioenergy Limited is engaged in the production of biofuels, with a primary focus on the ethanol sector.

Website trualtbioenergy.com
Listed 3 Oct 2025
Face Value ₹10

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/TRUALT.md for TruAlt Bioenergy Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More

More Agri & Food Products stocks → FII DII DataStock ScreenerNifty 50 HeatmapF&O Ban ListFII and DII flows, month by monthHow Tapetide Scores changed, month by monthStocks mutual funds are buying, month by month